Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Consolidated Profit & Loss account - Alembic Pharmaceuticals

Alembic Pharmaceuticals

BSE: 533573|NSE: APLLTD|ISIN: INE901L01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 23, 10:43
531.25
-6.85 (-1.27%)
VOLUME 433
LIVE
NSE
Oct 23, 10:43
532.60
-5.8 (-1.08%)
VOLUME 3,953
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Consolidated Profit & Loss account of Alembic Pharmaceuticals

------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 3,806.61 3,124.67 3,130.92 3,162.39 2,032.98
Less: Excise/Sevice Tax/Other Levies 0.00 0.63 29.46 0.00 15.05
Revenue From Operations [Net] 3,806.61 3,124.04 3,101.46 3,162.39 2,017.93
Other Operating Revenues 128.07 6.14 3.69 3.59 38.19
Total Operating Revenues 3,934.68 3,130.18 3,105.15 3,165.98 2,056.13
Other Income 9.38 7.03 2.02 7.27 2.30
Total Revenue 3,944.06 3,137.21 3,107.17 3,173.25 2,058.43
EXPENSES
Cost Of Materials Consumed 850.04 725.75 703.87 653.94 540.49
Purchase Of Stock-In Trade 234.93 201.87 224.18 223.13 246.93
Changes In Inventories Of FG,WIP And Stock-In Trade -92.28 -42.06 -69.95 -95.94 -72.89
Employee Benefit Expenses 746.69 622.81 558.83 472.85 306.76
Finance Costs 18.41 3.40 5.23 5.43 1.78
Depreciation And Amortisation Expenses 115.23 105.46 82.97 72.21 44.41
Other Expenses 1,321.72 978.72 1,072.94 905.32 631.87
Total Expenses 3,194.74 2,595.95 2,578.07 2,236.94 1,699.36
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 749.32 541.26 529.10 936.31 359.07
Profit/Loss Before Tax 749.32 541.26 529.10 936.31 359.07
Tax Expenses-Continued Operations
Current Tax 178.14 123.61 122.40 198.75 76.35
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 7.39
Deferred Tax -17.29 -2.16 -0.21 17.37 7.39
Tax For Earlier Years -4.10 -1.10 0.00 0.00 0.00
Total Tax Expenses 156.75 120.35 122.19 216.12 76.35
Profit/Loss After Tax And Before ExtraOrdinary Items 592.57 420.91 406.91 720.19 282.72
Profit/Loss From Continuing Operations 592.57 420.91 406.91 720.19 282.72
Profit/Loss For The Period 592.57 420.91 406.91 720.19 282.72
Minority Interest 1.08 -0.19 0.09 0.00 0.00
Share Of Profit/Loss Of Associates -9.28 -8.09 -3.83 -0.15 0.20
Consolidated Profit/Loss After MI And Associates 584.37 412.63 403.17 720.04 282.92
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 31.00 22.00 21.00 38.00 15.00
Diluted EPS (Rs.) 31.00 22.00 21.00 38.00 15.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 90.91 75.41 75.41 79.41 65.98
Tax On Dividend 0.00 15.35 15.35 0.00 13.43
Source : Dion Global Solutions Limited

Results of Alembic Pharma

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for alembicpharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.